155 related articles for article (PubMed ID: 17923478)
1. DNA accelerates the inhibition of human cathepsin V by serpins.
Ong PC; McGowan S; Pearce MC; Irving JA; Kan WT; Grigoryev SA; Turk B; Silverman GA; Brix K; Bottomley SP; Whisstock JC; Pike RN
J Biol Chem; 2007 Dec; 282(51):36980-6. PubMed ID: 17923478
[TBL] [Abstract][Full Text] [Related]
2. Cross-class inhibition of the cysteine proteinases cathepsins K, L, and S by the serpin squamous cell carcinoma antigen 1: a kinetic analysis.
Schick C; Pemberton PA; Shi GP; Kamachi Y; Cataltepe S; Bartuski AJ; Gornstein ER; Brömme D; Chapman HA; Silverman GA
Biochemistry; 1998 Apr; 37(15):5258-66. PubMed ID: 9548757
[TBL] [Abstract][Full Text] [Related]
3. Inhibition of Plasmodium falciparum cysteine protease falcipain-2 by a human cross-class inhibitor serpinB3: A mechanistic insight.
Alam B; Biswas S
Biochim Biophys Acta Proteins Proteom; 2019 Sep; 1867(9):854-865. PubMed ID: 31247344
[TBL] [Abstract][Full Text] [Related]
4. Evidence that serpin architecture intrinsically supports papain-like cysteine protease inhibition: engineering alpha(1)-antitrypsin to inhibit cathepsin proteases.
Irving JA; Pike RN; Dai W; Brömme D; Worrall DM; Silverman GA; Coetzer TH; Dennison C; Bottomley SP; Whisstock JC
Biochemistry; 2002 Apr; 41(15):4998-5004. PubMed ID: 11939796
[TBL] [Abstract][Full Text] [Related]
5. The serpin SQN-5 is a dual mechanistic-class inhibitor of serine and cysteine proteinases.
Al-Khunaizi M; Luke CJ; Askew YS; Pak SC; Askew DJ; Cataltepe S; Miller D; Mills DR; Tsu C; Brömme D; Irving JA; Whisstock JC; Silverman GA
Biochemistry; 2002 Mar; 41(9):3189-99. PubMed ID: 11863458
[TBL] [Abstract][Full Text] [Related]
6. The novel bovine serpin endopin 2C demonstrates selective inhibition of the cysteine protease cathepsin L compared to the serine protease elastase, in cross-class inhibition.
Hwang SR; Stoka V; Turk V; Hook VY
Biochemistry; 2005 May; 44(21):7757-67. PubMed ID: 15909990
[TBL] [Abstract][Full Text] [Related]
7. Heparin enhances serpin inhibition of the cysteine protease cathepsin L.
Higgins WJ; Fox DM; Kowalski PS; Nielsen JE; Worrall DM
J Biol Chem; 2010 Feb; 285(6):3722-3729. PubMed ID: 19959474
[TBL] [Abstract][Full Text] [Related]
8. Characterization by spectroscopic, kinetic and equilibrium methods of the interaction between recombinant human cystatin A (stefin A) and cysteine proteinases.
Pol E; Olsson SL; Estrada S; Prasthofer TW; Björk I
Biochem J; 1995 Oct; 311 ( Pt 1)(Pt 1):275-82. PubMed ID: 7575465
[TBL] [Abstract][Full Text] [Related]
9. Crystal structure of the parasite protease inhibitor chagasin in complex with a host target cysteine protease.
Ljunggren A; Redzynia I; Alvarez-Fernandez M; Abrahamson M; Mort JS; Krupa JC; Jaskolski M; Bujacz G
J Mol Biol; 2007 Aug; 371(1):137-53. PubMed ID: 17561110
[TBL] [Abstract][Full Text] [Related]
10. Cystatin M/E is a high affinity inhibitor of cathepsin V and cathepsin L by a reactive site that is distinct from the legumain-binding site. A novel clue for the role of cystatin M/E in epidermal cornification.
Cheng T; Hitomi K; van Vlijmen-Willems IM; de Jongh GJ; Yamamoto K; Nishi K; Watts C; Reinheckel T; Schalkwijk J; Zeeuwen PL
J Biol Chem; 2006 Jun; 281(23):15893-9. PubMed ID: 16565075
[TBL] [Abstract][Full Text] [Related]
11. The role of Gly-4 of human cystatin A (stefin A) in the binding of target proteinases. Characterization by kinetic and equilibrium methods of the interactions of cystatin A Gly-4 mutants with papain, cathepsin B, and cathepsin L.
Estrada S; Nycander M; Hill NJ; Craven CJ; Waltho JP; Björk I
Biochemistry; 1998 May; 37(20):7551-60. PubMed ID: 9585570
[TBL] [Abstract][Full Text] [Related]
12. Resistance of cathepsin L compared to elastase to proteolysis when complexed with the serpin endopin 2C, and recovery of cathepsin L activity.
Hwang SR; Stoka V; Turk V; Hook V
Biochem Biophys Res Commun; 2006 Feb; 340(4):1238-43. PubMed ID: 16414353
[TBL] [Abstract][Full Text] [Related]
13. The contribution of N-terminal region residues of cystatin A (stefin A) to the affinity and kinetics of inhibition of papain, cathepsin B, and cathepsin L.
Estrada S; Pavlova A; Björk I
Biochemistry; 1999 Jun; 38(22):7339-45. PubMed ID: 10353845
[TBL] [Abstract][Full Text] [Related]
14. Crystal structure of Stefin A in complex with cathepsin H: N-terminal residues of inhibitors can adapt to the active sites of endo- and exopeptidases.
Jenko S; Dolenc I; Guncar G; Dobersek A; Podobnik M; Turk D
J Mol Biol; 2003 Feb; 326(3):875-85. PubMed ID: 12581647
[TBL] [Abstract][Full Text] [Related]
15. X-ray crystal structure of MENT: evidence for functional loop-sheet polymers in chromatin condensation.
McGowan S; Buckle AM; Irving JA; Ong PC; Bashtannyk-Puhalovich TA; Kan WT; Henderson KN; Bulynko YA; Popova EY; Smith AI; Bottomley SP; Rossjohn J; Grigoryev SA; Pike RN; Whisstock JC
EMBO J; 2006 Jul; 25(13):3144-55. PubMed ID: 16810322
[TBL] [Abstract][Full Text] [Related]
16. Squamous cell carcinoma antigen is a potent inhibitor of cysteine proteinase cathepsin L.
Takeda A; Yamamoto T; Nakamura Y; Takahashi T; Hibino T
FEBS Lett; 1995 Feb; 359(1):78-80. PubMed ID: 7851535
[TBL] [Abstract][Full Text] [Related]
17. Cathepsin V, a novel and potent elastolytic activity expressed in activated macrophages.
Yasuda Y; Li Z; Greenbaum D; Bogyo M; Weber E; Brömme D
J Biol Chem; 2004 Aug; 279(35):36761-70. PubMed ID: 15192101
[TBL] [Abstract][Full Text] [Related]
18. The role of the second binding loop of the cysteine protease inhibitor, cystatin A (stefin A), in stabilizing complexes with target proteases is exerted predominantly by Leu73.
Pavlova A; Björk I
Eur J Biochem; 2002 Nov; 269(22):5649-58. PubMed ID: 12423365
[TBL] [Abstract][Full Text] [Related]
19. Inhibitory mechanism of a cross-class serpin, the squamous cell carcinoma antigen 1.
Masumoto K; Sakata Y; Arima K; Nakao I; Izuhara K
J Biol Chem; 2003 Nov; 278(46):45296-304. PubMed ID: 12949073
[TBL] [Abstract][Full Text] [Related]
20. Inhibition of the cysteine proteinases cathepsins K and L by the serpin headpin (SERPINB13): a kinetic analysis.
Jayakumar A; Kang Y; Frederick MJ; Pak SC; Henderson Y; Holton PR; Mitsudo K; Silverman GA; EL-Naggar AK; Brömme D; Clayman GL
Arch Biochem Biophys; 2003 Jan; 409(2):367-74. PubMed ID: 12504904
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
